BOWDOIN COLLEGE
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1794-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- https://www.bowdoin.edu/
Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 1
1 (33.3%)Online Mindfulness-based Tic Reduction (Phase Two)
Not Applicable
Completed
- Conditions
- Persistent Tic DisorderTourette Syndrome
- First Posted Date
- 2018-12-11
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- Bowdoin College
- Target Recruit Count
- 37
- Registration Number
- NCT03771235
- Locations
- 🇺🇸
Bowdoin College, Brunswick, Maine, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Online Mindfulness-based Tic Reduction
Not Applicable
Completed
- Conditions
- Tourette SyndromeTic Disorders
- First Posted Date
- 2018-05-15
- Last Posted Date
- 2019-07-09
- Lead Sponsor
- Bowdoin College
- Target Recruit Count
- 6
- Registration Number
- NCT03525626
- Locations
- 🇺🇸
Bowdoin College, Brunswick, Maine, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Vasopressin Effects on Human Social Communication
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- Drug: Vasopressin, Arginine, ADHDrug: Placebo; Sterile Saline
- First Posted Date
- 2011-04-01
- Last Posted Date
- 2017-11-06
- Lead Sponsor
- Bowdoin College
- Target Recruit Count
- 225
- Registration Number
- NCT01327027
- Locations
- 🇺🇸
Maine Medical Center, McGeachey Hall, OP Psych, Portland, Maine, United States
News
No news found